Case Report
Congenital Hypothyroidism: An Unusual Combination of Biochemical Abnormalities
Table 1
Results of serial biochemical investigations.
| Day of life | Reference value | 44 | 51 | 52 | 55 | 59 | 70 | Day following initiation of therapy | −11 | −4 | −3 | 0 | 4 | 15 |
| Serum bilirubin (total) | <1.2 mg/dl | 14.9 | 16 | 15.2 | 14.6 | 16.3 | 3.8 | Serum bilirubin (direct) | <0.2 mg/dl | 1.1 | 1.3 | 1.3 | 1.3 | 1.1 | 0.9 | Serum bilirubin (indirect) | 1.0 mg/dl | 13.8 | 14.7 | 13.9 | 13.3 | 15.2 | 2.9 | Serum protein, total | 5.1–7.3 g/dl | — | 5.6 | 5.3 | 5.6 | 5.7 | 6.0 | Serum albumin | 2.2–4.8 | — | 3.4 | 3.3 | 3.4 | 3.6 | 4.1 | SGOT (AST) | 9–80 u/l | — | 298 | 278 | 225 | 220 | 40 | SGPT (ALT) | 13–45 u/l | — | 174 | 157 | 148 | 135 | 20 | Serum alkaline phosphatase | 150–420 u/l | — | 239 | 213 | 226 | 221 | 247 | Serum free T3 | 0.91–4.4 pg/ml | — | — | — | <1 | — | 4.1 | Serum free T4 | 0.8–2.0 ng/dl | — | — | — | <0.4 | — | 1.4 | TSH | 0.8–8.2 microIU/ml | — | — | — | 500 | — | 37.8 |
|
|